J Korean Liver Cancer Stud Search


Journal of the Korean Liver Cancer Study 2006;6(1):20-24.
Published online June 30, 2006.
A Case of Successful Treatment for Recurrent Hepatocellular Carcinoma with Long term Survival
Jin Hyoung Lee1, Ja Kyung Kim1, Hwa Sook Kim1, Sang Hoon Ahn1, Chae Yoon Chon1, Young Myoung Moon1, Kwang-Hyub Han1, Woo Jung Lee2, Young Nyun Park3, Seung Hyoung Kim4, Kwang Hoon Lee4, Do Yun Lee4, Jong Tae Lee4
1Departments of Internal Medicine,Yonsei University College of Medicine, Seoul, Korea
2Departments of Surgery,Yonsei University College of Medicine, Seoul, Korea
3Departments of Pathology,Yonsei University College of Medicine, Seoul, Korea
4Departments of Radiology,Yonsei University College of Medicine, Seoul, Korea
5Departments of Yonsei Liver Cancer Special Clinic, Yonsei University College of Medicine, Seoul, Korea
Correspondence:  Kwang-Hyub Han,
Email: gihankhys@yumc.yonsei.ac.kr
Copyright ©2006 by The Korean Liver Cancer Association
The long term results of surgery for hepatocelluar carcinoma are not satisfactory, because the high incidence of intrahepatic tumor recurrence, with a 5-year acturial recurrence rate of 75% to 100%. The risk factors for postoperative recurrence such as venous invasion, presence of satellite nodules, large tumor size, advanced TNM stages are the best-established. For the management of postoperative recurrence, studies largely focused on the recurrence in the remnant liver. The therapeutic modalities commonly used for surgical resection, TACE, percutaneous ethanol injection (PEIT), and systemic chemotherapy. We report a case of recurrent hepatocellular carcinoma after curative resection, successfully treated by TACE, TACI, and systemic chemotherapy with long term survival.
Key Words: Hepatocellular carcinoma; Recurrence; Risk factors; Treatment modality


Browse all articles >

Editorial Office
1527 Gangnam Finance Plaza (FASTFIVE), 419 Teheran-ro, Gangnam-gu, Seoul 06160, Korea
Tel: +82-2-313-1900    E-mail: liver@klcsg.or.kr                

Copyright © 2019 by The Korean Liver Cancer Association. All rights reserved.

Developed in M2community

Close layer
prev next